詳細

【英文原著】
1. Ando Y, Ueda M:

Antibody therapy for familial amyloid polyneuropathy.

Amyloid, 24: 113-114, 2017

 

2. Huang G, Ueda M, Tasaki M, Yamashita T, Misumi Y, Masuda T, Suenaga G, Inoue Y, Kinoshita Y, Matsumoto S, Mizukami M, Tsuda Y, Nomura T, Obayashi K, Ando Y:

Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.

Amyloid, 24: 24-29, 2017

 

3. Ikenoshita S, Yamashita S, Sakamoto T, Misumi Y, Ando Y:

Hemi-atrophy of tongue with contralateral hemiparesis in a patient with MADSAM.

J. Clin. Neurol., 2017, in press.

 

4. Inatomi Y, Nakajima M, Yonehara T, Ando Y:

Ipsilateral hemiparesis in ischemic stroke patients.

Acta Neurol. Scand., 2017, in press.

 

5. Inatomi Y, Nakajima M, Yonehara T, Ando Y:

Clinical characteristics of patients seizure following the 2016 Kumamoto earthquake.

J. Clin. Neurosci., 2017, in press.

 

6. Inatomi Y, Nakajima M, Yonehara T, Ando Y:

Successful switching of anticoagulants in a patient with superficial siderosis and atrial fibrillation.

Neurol. Clin. Nerosci., 2017, in press.

 

7. Inatomi Y, Nakajima M, Yonehara T, Ando Y:

Ipsilateral Tremor-Like Grasp Reaction in a Patient with Ischemic Stroke.

Cogn. Behav. Neurol., 2017, in press.

 

8. Izaki A, Obayashi K, Suenaga G, Ueda M, Yamashita T, Tasaki M, Yanagisawa Y, Masuda T, Misumi Y, Ando Y:

In vitro and in vivo assessment of novel derivatives for detecting various amyloid deposits.

Amyloid, 2017, in press.

 

9. Kawano H, Bivard A, Lin L, Ma H, Cheng X, Aviv R, O’Brien B, Butcher K, Lou M, Zhang J, Jannes J, Dong Q, Levi CR, Parsons MW:

Perfusion computed tomography in patients with stroke thrombolysis.

Brain, 2017, in press.

 

10. Maeda Y, Nakane S, Higuchi O, Nakamura H, Komori A, Migita K, Mukaino A, Umeda M, Ichinose K, Tamai M, Kawashiri SY, Sakai W, Yatsuhashi H, Kawakami A, Matsuo H:

Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis.

Mod. Rheumatol. 2017, in press.

 

11. Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y:

Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.

Neurology, 2017, in press.

 

12. Matsumoto S, Ueda M, Yamashita T, Amano T, Misumi Y, Tasaki M, Masuda T, Mizukami M, Furuya H, Ando Y:

A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.

Amyloid, 2017, in press.

 

13. Misumi Y, Ueda M, Yamashita T, Masuda T, Kinoshita Y, Tasaki M, Nagase T, Ando Y:

Novel screening for transthyretin amyloidosis by using fat ultrasonography.

Ann. Neurol., 2017, in press.

 

14. Mizukami M, Ueda M, Tasaki M, Misumi Y, Masuda T, Matsumoto S, Yamashita T, Ando Y:

Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study.

Amyloid, 2017, in press.

 

15. Morimoto N, Takahashi S, Inaba T, Takamiya M, Kageyama Y, Morimoto M, Takahashi Y, Nishimura H, Nakane S, Abe K:

A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm.

J. Clin. Neurosci., 2017, in press.

 

16. Nakane S, Furutani K, Harada M, Urushihara R, Matsui N, Izumi Y, Kaji R:

Multimodal analysis based on high-field magnetic resonance and motor evoked potentials.

Clin. Exp. Neuroimmunol., 2017, in press.

 

17. Nishi S, Muso E, Shimizu A, Sugiyama H, Yokoyama H, Ando Y, Goto S, Fujii H:

A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study.

Clin. Exp. Nephrol. 2017, in press.

 

18. Nomura T, Yamashita T, Misumi Y, Ueda M, Masuda T, Tasaki M, Ando Y:

A case with a novel variant transthyretin A36D presenting cardiac phenotype.

Amyloid, 2017, in press.

 

19. Obayashi K, Ueda M, Yamashita T, Tasaki M, Izaki A, Yanagisawa Y, Masuda T, Misumi Y, Ando Y:

Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP) ATTR V30M.

Amyloid, 2017, in press.

 

 

20. Oda S, Utsunomiya D, Nakaura T, Yuki H, Kidoh M, Morita K, Takashio D, Yamamuro M, Izumiya Y, Hirakawa K, Ishida T, Tsujita K, Ueda M, Yamashita T, Ando Y, Hata H, Yamashita Y:

Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging.

Circ. J., 2017, in press.

 

 

21. Sakai W, Nakane S, Urasaki E, Toyoda K, Sadakata E, Nagaishi A, Fukudome T, Yamakawa Y, Matsuo H: 

The Cross-Sectional Area of Paraspinal Muscles Predicts the Efficacy of Deep Drain Stimulation for Camptocormia.

J. Parkinsons Dis., 2017, in press.

 

22. Singu T, Inatomi Y, Yonehara T, Ando Y:

Calcified Amorphous Tumor Causing Shower Embolism to the Brain: A Case Report with Serial Echocardiographic and Neuroradiologic Images and a Review of the Literature.

J. Stroke Cerebrovasc. Dis., 2017, in press.

 

 

23. Smith E, Cieslak A, Barber B, Chen Y, Chen J, Donnini I, Edwards J, Field TS, Frayne R, Hegedus J, Hanganu V, Ismail Z, Kanji J, Nakajima M, Noor R, Peca S, Sahlas D, Sharma M, Sposato L, Swartz R, Zerna C, Black S, Hachinski V:

Therapeutic strategies and drug development for vascular cognitive impairment.

J. Am. Heart Assoc., 2017, in press.

 

24. Tasaki M, Ueda M, Obayashi K, Kinoshita Y, Matsumoto S, Mizukami M, Masuda T, Misumi Y, Yamashita T, Ando Y:

Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience in Kumamoto University.

Amyloid, 2017, in press.

 

25. Tawara N, Yamashita S, Zhang X, Korogi M, Zhang Z, Doki T, Matsuo Y, Nakane S, Maeda S, Sugie K, Suzuki N, Aoki M, Ando Y:

Pathomechanisms of anti-cN1A autoantibodies in sporadic inclusion body myositis.

Ann. Neurol., 2017, in press.

 

26. Tsuda Y, Misumi Y, Ueda M, Tasaki M, Huang G, Masuda T, Suenaga G, Inoue Y, Kinoshita Y, Obayashi K, Yamashita T, Ando Y:

Iatrogenic systemic transthyretin amyloid deposits in a case with domino liver transplantation: an autopsy case study.

Amyloid, 2017, in press.

 

27. Yamamoto F, Yamashita S, Kawano H, Tanigawa T, Mihara Y, Gonoi T, Ando Y:

Meningitis and ventriculitis due to Nocardia araoensis infection.

Intern Med. 2017, in press.

 

28. Yamashita T, Ueda M, Tasaki M, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Ando Y:

Establishment of a diagnostic center for amyloidosis in Japan by Kumamoto University.

Amyloid, 2017, in press.

 

29. Yanagisawa Y, Obayashi K, Tasaki M, Izaki A, Masuda T, Misumi Y, Ueda M, Yamashita T, Ando Y:

Clinicopathological characteristics of a patient with ureteral amyloidosis.

Amyloid, 2017, in press.

 

30. Watanabe T, Obayashi K, Misumi Y, Tasaki M, Shinriki S, Ando T, Akagami T, Ueda M, Yamashita T, Hirotani S, Ando Y:

Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.

Amyloid, 2017, in press.

 

31. Ando T, Goto Y, Mano K, Ueda A, Ando Y, Mizuta I, Mizuno T:

CADASIL Presenting as Acute Bilateral Multiple Subcortical Infarcts without a Characteristic Temporal Pole or Any External Capsule Lesions.

Intern Med, 55: 2873-2876, 2016

 

 

32. Ando Y, Sekijima Y, Obayashi K, Yamashita T, Ueda M, Misumi Y, Morita H, Machii K, Ohta M, Takata A, Ikeda S:

Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyoid polyneuropathy (TTR-FAP) with Val30Met and non-Varl30Met: A phase III, open-label study.

J. Neurol. Sci, 15: 266-271, 2016

 

33. Asakura K, Yanai S, Nakamura S, Kawaski1 K, Eizuka M, Ishida K, Sugai T, Ueda M, Yamashita T, Ando Y, Matsumoto T:  Endoscopic Findings of Small-Bowel Lesions in Familial Amyloid Polyneuropathy: A Case Report.

Medicine, 95: e2896, 2016

 

34. Azuma M, Hirai T, Yamada K, Yamashita S, Ando Y, Tateishi M, Iryo Y, Yoneda T, Kitajima M, Wang Y, Yamashita Y:

Lateral asymmetry and spatial difference of iron deposition in the substantia nigra of patients with parkinson disease measured with quantitative susceptibility mapping.

AJNR Am. J. Neuroradiol, 37: 782-788, 2016

 

35. Fukasawa K, Higashimoto Y, Motomiya Y, Uji Y, Ando Y:

Influence of heparin molecular size on the induction of C- terminal unfolding in β2-microglobulin.

Mol. Biol. Res. Commun, 5: 225-232, 2016

 

36. Higuchi O, Nakane S, Sakai W, Maeda Y, Niino M, Takahashi T, Fukazawa T, Kikuchi S, Fujihara K, Matsuo H:

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.

Neurol. Neuroimmunol. Neuroinflamm, 3: e263, 2016

 

37. Hosoi A, Su Y, Torikai M, Jono H, Ishikawa D, Soejima K, Higuchi H, Guo J, Ueda M, Suenaga G, Motokawa H, Ikeda T, Senju S, Nakashima T, Ando Y:

Novel Antibody for the Treatment of Transthyretin Amyloidosis.

J. Biol. Chem, 25: 25096-25105, 2016

 

38. Inoue Y, Nakajima M, Uetani H, Hirai T, Ueda M, Kitajima M, Utsunomiya D, Watanabe M, Hashimoto M, Ikeda M, Yamashita Y, Ando Y:

Diagnostic significance of cortical superficial siderosis for Alzheimer’s disease in patients with cognitive impairment.

AJNR Am. J. Neuroradiol, 37: 223-227, 2016

 

39. Inoue Y, Nakajima M, Hirai T, Ando Y:

Reply.

AJNR Am J Neuroradiol, 37: E26, 2016

 

40. Ishizaki M, Kedoin C, Ueyama H, Maeda Y, Yamashita S, Ando Y:

Utility of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy.

Neuromuscul. Disord, 27: 24-28, 2017

 

41. Jono H, Su Y, Obayashi K, Tanaka Y, Ishiguro A, Nishimura H, Shinriki S, Ueda M, Ikeda K, Yamagata K, Ichihara K, Ando Y, Scientific Committee for the Asia-Pacific Federation of Clinical Biochemistry: 

Sources of variation of transthyretin in healthy subjects in East and Southeast Asia: Clinical and experimental evidence for the effect of alcohol on transthyretin metabolism.

Clin. Chim. Acta, 458: 5-11, 2016

 

42. Kamada M, Nakane S, Matsui N, Higuchi O, Sakai W, Fujita K, Izumi Y, Matsuo H, Kaji R:

Ocular myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies: Two new cases and a systematic literature review.

Clin Exp Neuroimmunol, 7: 168-173, 2016

 

43. Kasagi T, Nobata H, Suzuki K, Miura N, Banno S, Takami A, Yamashita T, Ando Y, Imai H:

Light Chain Deposition Disease Diagnosed with Laser Micro-dissection, Liquid Chromatography, and Tandem Mass Spectrometry of Nodular Glomerular Lesions.

Intern. Med, 56: 61-66, 2017

 

44. Kawano H, Bivard A, Lin L, Spratt N, Miteff F, Parsons M, Levi C:

The relationship between collateral status, contrast transit and contrast density in acute ischemic stroke.

Stroke, 47: 742-749, 2016

 

45. Kawano H, Levi C, Inatomi Y, Pagram H, Kerr E, Bivard A, Spratt N, Miteff F, Yonehara T, Ando Y, Parsons M:

International benchmarking for acute thrombolytic therapy implementation in Australia and Japan.

J. Clin. Neurosci, 29: 87-91, 2016

 

46. Kikukawa Y, Hata H, Ueda M, Yamashita T, Nasu S, Ide K, Ueno S, Ando Y, Mitsuya H, Okuno Y:

Successful Treatment of Amyloid Light-chain Amyloidosis in a Charcot-Marie-Tooth Disease Patient with Lenalidomide, Cyclophosphamide, and Dexamethasone.

Intern. Med, 55: 2707-2712, 2016

 

47. Kimura T, Fukushima S, Miyashita A, Aoi J, Jinnin M, Kosaka T, Ando Y, Matsukawa M, Inoue H, Kiyotani K, Park JH, Nakamura Y, Ihn H:

Myasthenic crisis and polymyositis induced by one dose of nivolumab.

Cancer Sci, 107; 1055-1058, 2016

 

48. Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G:

Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy.

Neurology, 87: 2220-2229, 2016

 

49. Kuki I, Kawawaki H, Okazaki S, Hattori Y, Horino A, Higuchi O, Nakane S:

Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis.

Brain Dev, 38: 605-608, 2016

 

50. Kukidome D, Nishikawa T, Sato M, Igata M, Kawashima J, Shimoda S, Matsui K, Obayashi K, Ando Y, Araki E:

Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy.

Diabet. Med, 33: 62-9, 2016

 

51. Maeda Y, Migita K, Higuchi O, Mukaino A, Furukawa H, Komori A, Nakamura M, Hashimoto S, Nagaoka S, Abiru S, Yatsuhashi H, Matsuo H, Kawakami A, Yasunami M, Nakane S:

Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.

PLoS One, 11: e0146048, 2016

 

52. Masuda T, Obayashi K, Ueda M, Fujimoto A, Tasaki M, Misumi Y, Ueda A, Nakane T, Yamashita T, Ando Y:

Therapeutic effects and prevention of recurrence of acquired idiopathic generalized anhidrosis via i.v. immunoglobulin treatment.

J. Dermatol, 43: 336-337, 2016

 

53. Merlini G, Lousada I, Ando Y, Dispenzieri A, Gertz MA, Grogan M, Maurer MS, Sanchorawala V, Wechalekar A, Palladini G, Comenzo RL:

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis.

Leukemia, 30: 1979-1986, 2016

 

54. Misumi Y, Narita Y, Oshima T, Ueda M, Yamashita T, Tasaki M, Obayashi K, Isono K, Inomata Y, Ando Y:

Recipient Aging Accelerates Acquired Transthyretin Amyloidosis After Domino Liver Transplantation.

Liver Transpl, 22: 656-664, 2016

 

55. Mori A, Yamashita S, Nakajima M, Hori H, Tawara A, Matsuo Y, Misumi Y, Ando Y:

CMAP decrement as a potential diagnostic marker for ALS.

Acta. Neurol. Scand, 134: 49-53, 2016

 

56. Mori Y, Yamashita S, Kato M, Masuda T, Takamatsu K, Kumamoto T, Sasaki R, Ando Y:

Thomsen disease with ptosis and abnormal MR findings.

Neuromuscul. Disord, 26: 805-808, 2016

 

57. Mukaino A, Nakane S, Higuchi O, Nakamura H, Miyagi T, Shiroma K, Tokashiki T, Fuseya Y, Ochi K, Umeda M, Nakazato T, Akioka S, Maruoka H, Hayashi M, Igarashi S, Yokoi K, Maeda Y, Sakai W, Matsuo H, Kawakami A:

Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren’s syndrome.

Mod. Rheumatol, 26: 708-715, 2016

 

58. Nakane S, Izumi Y, Oda M, Kaji R, Matsuo H:

A Potential Link between Amyotrophic Lateral Sclerosis and Bullous Pemphigoid: Six New Cases and a Systematic Review of the Literature.

Intern. Med, 55: 1985-1990, 2016

 

59. Nakane S, Higuchi O, Hamada Y, Maeda Y, Mukaino A, Sakai W, Kusunoki S, Matsuo H:

Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome.

J. Neuroimmunol, 15: 295-296, 2016

 

60. Nakane S, Mukaino A, Maeda Y, Higuchi O, Matsuo H, Ando Y:

Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey.

J. Neurol. Neurosurg. Psychiatry, 88: 367-368, 2017

 

61. Nakahara K, Nakane S, Nakajima M, Yamashita S, Mori T, Ando Y:

Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.

J. Neuroimmunol, 305: 182-185, 2017

 

62. Obayashi K, Ando Y, Araki E, Kukidome D, Nishikawa T, Sato M, Igata M, Kawashima J, Shimoda S, Matsui K:

Measurement of small fibre pain threshold values for the early detection of diabetic polyneuropathy.

Diabet. Med, 33: 62-69, 2016

 

63. Okumura K, Yamashita T, Masuda T, Misumi Y, Ueda A, Ueda M, Obayashi K, Jono H, Yamashita S, Inomata Y, Ando Y:

Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.

Amyloid, 23: 39-45, 2016

 

64. Shimazaki C, Fuchida S, Suzuki K, Ishida T, Imai H, Sawamura M, Takamatsu H, Abe M, Miyamoto T, Hata H, Yamada M, Ando Y:

Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.

Int. J. Hematol, 103: 79-85, 2016

 

65. Shindo S, Fujii K, Shirakawa M, Uchida K, Sugiura Y, Saito S, Ando Y, Yoshimura S:

Three-Dimensional Optical Frequency Domain Imaging Evaluation of Novel Dual-Layered Carotid Stent Implantation for Vulnerable Carotid Plaque.

J Stroke Cerebrovasc. Dis, 25: e31-32, 2016

 

66. Suenaga G, Ikeda T, Komohara Y, Takamatsu K, Kakuma T, Tasaki M, Misumi Y, Ueda M, Ito T, Senju S, Ando Y:

Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.

PLoS One, 11: e0163944, 2016

 

67. Sugimura Y, Hoshino H:

Difficulty in Applying Recombinant Tissue Plasminogen Activator (rt-PA).

Intern. Med, 55: 1027-8, 2016

 

68. Sugimura Y, Koike K, Terao S, Asada H:

Good outcome case of anterior cerebral artery dissection that was treated with recombinant tissue plasminogen activator and trapping with A3-A3 anastomosis surgery.

Neurol. Clin. Neurosci, 4: 5, 2016

 

69. Suzuki N, Mori-Yoshimura M, Yamashita S, Nakano S, Murata KY, Inamori Y, Matsui N, Kimura E, Kusaka H, Kondo T, Higuchi I, Kaji R, Tateyama M, Izumi R, Ono H, Kato M, Warita H, Takahashi T, Nishino I, Aoki M:

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.

Orphanet J. Rare Dis, 11: 146, 2016

 

70. Suzuki T, Kusumoto S, Yamashita T, Masuda A, Kinoshita S, Yoshida T, Takami-Mori F, Takino H, Ito A, Ri M, Ishida T, Komatsu H, Ueda M, Ando Y, Inagaki H, Iida S:

Labial salivary gland biopsy for diagnosing immunoglobulin light chain amyloidosis: a retrospective analysis.

Ann. Hematol, 95: 279-285, 2016

 

71. Takahashi H, Noto YI, Makita N, Kushimura-Okada Y, Ishii R, Tanaka A, Ohara T, Nakane S, Higuchi O, Nakagawa M, Mizuno T:

Myasthenic symptoms in anti-low-density lipoprotein receptor-related protein 4 antibody-seropositive amyotrophic lateral sclerosis: two case reports.

BMC Neurol, 16: 229, 2016

 

72. Tasaki M, Ueda M, Obayashi K, Motokawa H, Kinoshita Y, Suenaga G, Yanagisawa A, Toyoshima R, Misumi Y, Masuda T, Yamashita T, Ando Y:

Rapid detection of wild-type and mutated transthyretins.

Ann. Clin. Biochem, 53: 508-510, 2016

 

73. Tokunaga M, Beppu A, Tamura Y, Oowaki K, Tokunaga Y, Ishihara C, Shibata K, Tanaka K, Takayama M:

Relationship between improvement in GNRI, a nutritional index, and improvement in motor FIM in elderly stroke patients hospitalized in a Kaifukuki Rehabilitation Ward.

Jpn. J. Compr. Rehabil. Sci, 7: 7-12, 2016

 

74. Tokunaga M, Mori Y, Ogata Y, Tanaka Y, Uchino K, Maeda Y, Kamiyoshi M:

Predicting FIM gain in stroke patients by adding median FIM gain stratified by FIM score at hospital admission to the explanatory variables in multiple regression analysis –An analysis of the Japan Rehabilitation Detabase-.

Jpn. J. Compr. Rehabil. Sci, 7: 13-18, 2016

 

75. Tsuji W, Takeuchi E, Oka S, Yamashita T, Yotsumoto F:

 Localized primary amyloidosis of the breast: a case report and review of the literature.

BMC Surg, 16: 62, 2016

 

76. Yamashita T, Ueda M, Saga N, Nanto K, Tasaki M, Masuda T, Misumi Y, Oda S, Fujimoto A, Amano T, Takamatsu K, Yamashita S, Obayashi K, Matsui H, Ando Y:

Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D.

Amyloid, 23: 207-208, 2016

 

77. Yanagisawa A, Ueda M, Sueyoshi T, Nakamura E, Tasaki M, Suenaga G, Motokawa H, Toyoshima R, Kinoshita Y, Misumi Y, Yamashita T, Sakaguchi M, Westermark P, Mizuta H, Ando Y:

Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid.

Amyloid, 23: 26-32, 2016

 

78. Yoshimura Y, Kuwabara T, Shiraishi N, Kakizoe Y, Tasaki M, Obayashi K, Ando Y, Mukoyama M:

Transthyretin-related familial amyloidotic polyneuropathy found with abnormal urinalysis at a general health checkup.

Nephrology, 21: 341-342, 2016